PRA EBITDA Growth
35.33%TTM
Period ending:
PRA TTM EBITDA YoY %%
3398.67%-3544.79%
1992-12-312026-03-31
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
PRA ebitda growth history
Year-over-year EBITDA growth rate. The available trailing twelve months (ttm) series contains 134 observations from Dec 31, 1992 to Mar 31, 2026.
| Period ending | EBITDA Growth |
|---|---|
| 35.3334% | |
| 3.3207% | |
| -17.8654% | |
| 298.2838% | |
| 315.7401% | |
| 929.8463% | |
| 510.1686% | |
| -60.0628% | |
| -54.9561% | |
| -80.8158% | |
| -79.5248% | |
| -40.0987% | |
| -75.4092% | |
| -74.3483% | |
| -56.7688% | |
| 602.3425% | |
| 242.2929% | |
| 212.9838% | |
| 161.8063% | |
| 110.8349% | |
| -104.974% | |
| -2,872.8378% | |
| -599.9246% | |
| -270.0273% | |
| -169.3103% | |
| -90.2134% | |
| -58.8773% | |
| -46.4025% | |
| -31.4713% | |
| -61.8986% | |
| -29.9139% | |
| -30.2464% | |
| -42.3026% | |
| -22.2109% | |
| 5.2967% | |
| 32.4052% | |
| 58.8736% | |
| 25.2942% | |
| -20.1779% | |
| -41.5184% | |
| -49.3275% | |
| -44.1133% | |
| -28.9824% | |
| -27.8028% | |
| -19.3535% | |
| -28.2486% | |
| -30.717% | |
| -21.6872% | |
| -24.6688% | |
| 2.3322% | |
| 0.6306% | |
| 3.5698% | |
| 7.2665% | |
| -3.9767% | |
| 23.2416% | |
| 17.7211% | |
| 22.2941% | |
| 25.1276% | |
| 17.6424% | |
| 15.065% | |
| 5.2528% | |
| 6.0686% | |
| 2.2239% | |
| 25.2916% | |
| 39.4134% | |
| 25.7653% | |
| 39.3752% | |
| 2.183% | |
| -1.7571% | |
| 2.815% | |
| -2.0314% | |
| 18.7591% | |
| 20.9149% | |
| 27.9009% | |
| 53.7846% | |
| 64.7212% | |
| 80.3754% | |
| 102.2067% | |
| 22.1493% | |
| 8.6651% | |
| 3.622% | |
| -7.8424% | |
| 29.4363% | |
| 62.0255% | |
| 72.1829% | |
| 106.4194% | |
| 84.2866% | |
| 140.2572% | |
| 192.0935% | |
| 226.0115% | |
| 2,726.7264% | |
| 144.3411% | |
| 63.5881% | |
| -72.7732% | |
| -98.2792% | |
| -91.2561% | |
| -92.6792% | |
| -67.0958% | |
| -38.3035% | |
| -10.3447% |
Compare ebitda growth
All PRA financial metrics · PRA stock overview · How to interpret financial metrics
